FDA Drug Chief’s ‘Revenge’ Emails Revealed in Explosive Lawsuit

The head of the U.S. Food and Drug Administration’s drug division, Dr. George F. Tidmarsh, resigned on November 2, 2025, one ...

FDA flags cholesterol drug for possible effectiveness issues

The Food and Drug Administration has initiated a Class II recall of 141,984 bottles of atorvastatin calcium after tests ...
STAT

Experts worry FDA’s credibility is being shredded by scandal and ‘soap opera’

It was the latest shockwave to sweep through an agency beset by all kinds of tumult in recent months. In interviews, ...

Listeria outbreak puts focus on food recalls

Six people have died and 25 people have been hospitalized due to a listeria outbreak linked to now-recalled precooked pasta ...

Searching 'weight' can bring up Ozempic in results. It's a drug advertising loophole

There are strict rules about what drug companies can say in TV or print ads. But a new study shows there's a lot more wiggle ...

Exclusive: US FDA cleared pricey rare disease drug over reviewer objections

The U.S. FDA approved a pricey rare disease drug in September despite findings by its data reviewers that the treatment, ...

Novo Nordisk’s weight-loss drug Wegovy could soon have a new sales outlet in the U.S.

Telehealth company Hims & Hers Health Inc. said late Monday it is in “active discussions” with Denmark’s Novo Nordisk A/S to ...
Disability Scoop

Pediatrics Group Declines To Recommend Drug For Autism Touted By Trump Administration

New professional guidance to the nation's pediatricians advises against using a drug in children with autism that many families are clamoring for after it was hyped by federal officials.